Dori Pelled
Chief Operating Officer at Imel Biotherapeutics, Inc.
Dori Pelled active positions
| Companies | Position | Start | End |
|---|---|---|---|
Imel Biotherapeutics, Inc.
 Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Imel Biotherapeutics, Inc. develops treatment for mitochondrial disease. The company was founded on February 21, 2019 and is headquartered in United States. | Chief Operating Officer | 28/02/2019 | - |
Career history of Dori Pelled
Former positions of Dori Pelled
| Companies | Position | Start | End |
|---|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Chief Operating Officer | - | 24/06/2018 |
| Corporate Officer/Principal | 24/06/2018 | 30/06/2018 | |
| ENZYMOTEC LTD. | Chief Tech/Sci/R&D Officer | - | - |
Training of Dori Pelled
| Tel-Aviv University | Graduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Statistics
International
| Israel | 4 |
| United States | 3 |
Operational
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Enzymotec Ltd.
 Enzymotec Ltd. BiotechnologyHealth Technology Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel. | Health Technology |
Imel Biotherapeutics, Inc.
Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Imel Biotherapeutics, Inc. develops treatment for mitochondrial disease. The company was founded on February 21, 2019 and is headquartered in United States. | Commercial Services |
- Stock Market
- Insiders
- Dori Pelled
- Experience
